Lixia Geng – Trademark Portfolio

Entity Type: 01

Lixia Geng holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include NVPIXT and YIAYEAH. The owner is based in Jilin Province.

Group 6,Layaozi Village,Xiaogushan Town

Jilin Province 130700 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

YIAYEAH
YIAYEAH
Registered 2020
NVPIXT
NVPIXT
Registered 2020

Trademark Classifications

Lixia Geng's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Lixia Geng have?

Lixia Geng has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Lixia Geng file in?

Lixia Geng files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Lixia Geng's most well-known trademarks?

Lixia Geng's registered trademark portfolio includes well-known marks such as NVPIXT and YIAYEAH. These are among 2 currently registered trademarks in the portfolio.

What is Lixia Geng's trademark registration success rate?

Lixia Geng has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.